TerumoTSE:4543 -1.73%88 EV-to-FCF is 25.82 as of Jul. 12, 2026, which is 64% below its 10-year median of 72.23. GuruFocus rates TSE:4543 with a GF Score™ of 88/100 and a GF Value™ of 円3,137.96 (Significantly Undervalued). Among 416 Medical Devices & Instruments companies, Terumo ranks worse than 55.29% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Terumo's Enterprise Value is 円3,328,023 Mil.
Terumo's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円128,889 Mil. Therefore, Terumo's EV-to-FCF for today is 25.82.
The historical rank and industry rank for Terumo's EV-to-FCF or its related term are showing as below:
TSE:4543'
s EV-to-FCF Range Over the Past 10 Years
Min: 22.77 Med: 72.23 Max: 423.83
Current: 25.82
During the past 13 years, the highest EV-to-FCF of Terumo was 423.83. The lowest was 22.77. And the median was 72.23.
TSE:4543's EV-to-FCF is ranked worse than 55.29% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs TSE:4543: 25.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-12), Terumo's stock price is 円2189.00.
Terumo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円92.120. Therefore, Terumo's PE Ratio (TTM) for today is 23.76.
Terumo (TSE:4543) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Terumo's share price for today is 円2189.00.
Terumo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円92.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Terumo EV-to-FCF Related Terms
Terumo EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Terumo's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Terumo's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Terumo's EV-to-FCF falls into.
Terumo's current Enterprise Value is 円3,328,023 Mil.
Terumo's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円128,889 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo (TSE:4543) has a EV-to-FCF of 25.82 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Terumo and its competitors. This is 64% below median its historical median of 72.23. Over the past decade, Terumo's EV-to-FCF has ranged from 22.77 to 423.83. According to the industry distribution chart, Terumo ranks #230 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 55.3%.
Is Terumo's EV-to-FCF too high?
Terumo's current EV-to-FCF of 25.82 is 64% below median its 10-year median of 72.23. Over the past 10 years, this metric has ranged from a low of 22.77 to a high of 423.83. The Medical Devices & Instruments industry median EV-to-FCF is 23.36. Terumo's value of 25.82 is 10.6% above this industry median. Based on the distribution chart, Terumo ranks #230 out of 416 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Terumo has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #230 out of 416 companies for EV-to-FCF. This places Terumo in the lower half of its industry. The industry median EV-to-FCF is 23.36. Terumo's value of 25.82 is 10.6% above this benchmark. Historically, Terumo's own EV-to-FCF has ranged from 22.77 to 423.83 over the past decade. While the company's 10-year median is 72.23 vs. the industry median of 23.36, Terumo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terumo's current EV-to-FCF of 25.82 is 10.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Terumo and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terumo's current EV-to-FCF is 25.82, which is 64% below median its own 10-year median of 72.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TSE:4543) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,137.96, compared to a current price of 円2,189.00 — trading 30.2% below its estimated fair value. The current EV-to-FCF is 25.82, which is 64% below median its 10-year median of 72.23 and 10.6% above the Medical Devices & Instruments industry median of 23.36. Terumo's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Terumo (TSE:4543), the current EV-to-FCF is 25.82 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terumo (TSE:4543) Overvalued in 2026?
Based on GuruFocus' analysis, Terumo stock appears to be undervalued.
The current stock price of 円2,189.00 is trading 30.2% below its estimated GF Value™ of 円3,137.96.
GuruFocus considers Terumo to be Significantly Undervalued.
Key valuation signals for TSE:4543:
EV-to-FCF: 25.82 (64% below median its 10-year median of 72.23)
GF Value™: 円3,137.96 vs. price of 円2,189.00 (30.2% below fair value)
Industry Position: 10.6% above the Medical Devices & Instruments median (#230 of 416)
No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
88GF Score
Get the complete analysis for TSE:4543
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4543 has been successfully added to your 
